Over 42 lakh deaths prevented in India due to COVID vaccination in 2021: Lancet study

Jun 24, 2022

New Delhi [India], June 24 : COVID-19 vaccination drive in India prevented over 42 lakh deaths in 2021, according to the Lancet Infectious Diseases...

Covaxin 50 pc effective against symptomatic COVID: Lancet study

Nov 24, 2021

New Delhi [India], November 24 : Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to...

COVAXIN shows high safety, immunogenicity during phase 1 clinical trial: Lancet journal

Jan 22, 2021

New Delhi [India], January 22 : In a remarkable finding, India's indigenous Covid-19 vaccine--COVAXIN developed by the Bharat Biotech and Indian Council of Medical...

Lancet Infectious Diseases study compare well with phase 3 clinical trials of COVAXIN: Bharat Biotech

Nov 25, 2021

New Delhi [India], November 25 : Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR,...

Mobile health intervention can help to prevent secondary stroke: ICMR study

Feb 18, 2023

The results of the trial were published in the Lancet Global Health journal on February 14, 2023.

Half of Covid survivors show one symptom even after 2 years: Lancet Journal

May 12, 2022

New Delhi [India], May 12 : Two years after getting infected with COVID-19, health outcomes of people who have suffered hospitalisation, reported at least...